Morgan Stanley raised the firm’s price target on Bath & Body Works to $49 from $48 and keeps an Overweight rating on the shares. The firm leaves the Q3 report, in which Bath & Body “unexpectedly” delivered topline upside on core product strength and subsequently raised fiscal year guidance,

Bath & Body Works fiscal third-quarter performance topped analysts' estimates thanks to strong sales, and the retailer boosted its full-year outlook. The owner of Victoria’s Secret, Bath & Body Works and other chain stores earned $106 million, or 49 cents per share, for the period.